Benzinga - by Lisa Levin, Benzinga Editor.
On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended not buying ChargePoint Holdings, Inc. (NYSE: CHPT) because it's losing money.
Sell Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT), Cramer recommends. It's "way too speculative."
As for Navitas Semiconductor Corporation (NASDAQ: NVTS), Cramer says "so many semiconductors are making a ton of money here. We’re not going to buy one that is actually losing money."
Don’t forget to check out our premarket coverage here
Luminar Technologies, Inc. (NASDAQ: LAZR) is also "losing too much money," the "Mad Money" host said.
Cramer likes Taiwan Semiconductor Manufacturing Company Limited (NYSE: TSM) and recommends buying it. "My only risk there is China, and I am concerned, but I think it will be ok," he noted.
Regarding RTX Corporation (NYSE: RTX), "their commercial business has gotten very tough because of that problem with that one engine," Cramer says. "I don’t think we can touch it still."
Axon Enterprise, Inc. (NASDAQ: AXON), meanwhile, is a "very well-run company," Cramer says. "They do a lot of good things. I think it has been one of my longest-standing recommendations, and you should buy the stock," he added.
Price Action: Shares of Axon fell 2.1% to close at $215.41, while RTX slipped 0.01% to $73.30 on Thursday. Taiwan Semiconductor rose 0.5% to settle at $92.42, while Luminar Technologies fell 3.1% to close at $4.11 on Thursday. Navitas Semiconductor shares fell 0.8% to close at $6.25, while Phathom Pharmaceuticals fell 5.3% to settle at $9.66 on Thursday. ChargePoint shares declined 5.3% to close at $3.58 during Thursday’s session.
Now Read This: Top 5 Real Estate Stocks That Could Lead To Your Biggest Gains In Q4
Image: Shutterstock
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.